论文信息 - A European pharmacotherapeutic agent roflumilast exploring integrated preclinical and clinical evidence for SARS CoV‐2 mediated inflammation to organ damage - 字舞流文

A European pharmacotherapeutic agent roflumilast exploring integrated preclinical and clinical evidence for SARS CoV‐2 mediated inflammation to organ damage

Imran Kazmi | F. Al-Abbasi | V. Subramaniyan | W. Almalki | N. Fuloria | S. Fuloria | Y. Singh | G. Gupta | Sobhit Singh Rajput | N. Joshi